Crossmark

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Crossref DOI link: https://doi.org/10.1186/s12885-016-2671-9

Published Online: 2016-09-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Vita, Ferdinando

Ventriglia, Jole

Febbraro, Antonio

Laterza, Maria Maddalena

Fabozzi, Alessio

Savastano, Beatrice

Petrillo, Angelica

Diana, Anna

Giordano, Guido

Troiani, Teresa

Conzo, Giovanni

Galizia, Gennaro

Ciardiello, Fortunato

Orditura, Michele
License Information

License valid from 2016-09-02